CDC Quietly Revokes RT-PCR Emergency Use Authorization Because They Counted Covid-19 and Influenza Together

[AMart]

The CDC announced, albeit quietly, on Wednesday that the RT-PCR tests used to tell millions of Americans they’re infected with Covid-19 has been unable to accurately differentiate between the various coronaviruses. Of particular note is the inability of these tests to know whether someone is infected with Covid-19 or influenza.

To be clear, this is not a new development. These assays have been known for years to be unable to distinguish between the different types of coronaviruses, but they ran with it anyway. According to the CDC website [emphasis added]:

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

"CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses."

CDC Quietly Revokes RT-PCR Emergency Use Authorization Because They Counted Covid-19 and Influenza Together - 🔔 The Liberty Daily

If you love the news, check out The Liberty Daily's homepage. Here’s a punch in the gut for a nation that’s already hurting. As it turns out, the so-called “gold standard” testing referenced by so many “doctors” like Anthony Fauci, as well as government officials across the board, has had its...

thelibertydaily.com

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

https://www.cdc.gov/csels/dls/locs/...-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html

CDC urges labs to use COVID tests that can differentiate from flu​

Laboratories have until the end of the year to make changes to their testing practices​

CDC urges labs to use COVID tests that can differentiate from flu

The Centers for Disease Control and Prevention (CDC) urged labs this week to stock clinics with kits that can test for both the coronavirus and the flu as the "influenza season" draws near.

www.foxnews.com

Scamdemic

 

[Care4all]

Makes sense to me.

It's important to differentiate whether those being tested, have the flu or the corona virus. There are antiviral meds specifically to treat the influenza virus and medical care is different, than medical treatment for the corona virus.